The president said that, because of his executive order, prescription drug prices would be cut “almost immediately.” Here's ...

The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.

Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

In the face of such pressure, pharmaceutical companies are eager to reduce the cost of drug development so that ... and more accurate clinical trial periods. More data and faster analysis mean ...

If prescription savings are to be passed on to Americans not on Medicare, Congress likely would have to pass a law to enact ...

While Trump has not yet turned to price controls to address America‘s absurdly high drug prices, Monday‘s executive order ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

In the second part of his Pharma Commerce video interview, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, ...

If the goals of his executive order are achieved, price reductions would not happen “almost immediately,” experts say.